At a glance
ClinicalIndex Comparison RecordN/ACompleted· 383 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Women and Risk of Type 2 Diabetes
In Brief
An observational study for Type 2 Diabetes Mellitus. Completed, enrolled 383 participants across 1 site.
Detailed Summary
This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related health issues in pregnancy in a multiethnic population. The investigators will now update the information about the health status of these women to study the development of risk factors for type 2 diabetes and cardiovascular diseases.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesNorway
CollaboratorsNorwegian Diabetes Association
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartAug 2019
Primary CompletionMar 2022
TodayJul 2026
First PostedMar 12, 2019
Enrollment StartAug 27, 2019
Primary CompletionMar 30, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.3 years ago